FASN and neoplasm: These results are in agreement with data showing that FASN inhibitors promote cell death and cell cycle arrest, along with the increased expression of both p21WAF1/Cip1 and p53 in colon, breast, gastrointestinal and human melanoma tumor cells [45], [78]–[80].